Purification of KBF1, a common factor binding to both H-2 and beta 2-microglobulin enhancers
about
Two genes encode factors with NF-kappa B- and H2TF1-like DNA-binding propertiesCloning of the DNA-binding subunit of human nuclear factor kappa B: the level of its mRNA is strongly regulated by phorbol ester or tumor necrosis factor alphaA novel NF-kappa B complex containing p65 homodimers: implications for transcriptional control at the level of subunit dimerizationDimerization of NF-KB2 with RelA(p65) regulates DNA binding, transcriptional activation, and inhibition by an I kappa B-alpha (MAD-3)The NF-kappa B precursor p105 and the proto-oncogene product Bcl-3 are I kappa B molecules and control nuclear translocation of NF-kappa BRegulation of the mouse alpha A-crystallin gene: isolation of a cDNA encoding a protein that binds to a cis sequence motif shared with the major histocompatibility complex class I gene and other genesCompilation of transcription regulating proteinsA large protein containing zinc finger domains binds to related sequence elements in the enhancers of the class I major histocompatibility complex and kappa immunoglobulin genesKBF1 (p50 NF-kappa B homodimer) acts as a repressor of H-2Kb gene expression in metastatic tumor cellsH-2RIIBP, a member of the nuclear hormone receptor superfamily that binds to both the regulatory element of major histocompatibility class I genes and the estrogen response elementCytoplasmic retention, DNA binding and processing of the NF-kappa B p50 precursor are controlled by a small region in its C-terminusThe p50 subunit of NF-kappa B associates with the NF-IL6 transcription factor.Angiotensinogen gene-inducible enhancer-binding protein 1, a member of a new family of large nuclear proteins that recognize nuclear factor kappa B-binding sites through a zinc finger motifInfluence of 5' flanking sequences on TL and H-2 expression in transfected L cells.Identification and purification of a human immunoglobulin-enhancer-binding protein (NF-kappa B) that activates transcription from a human immunodeficiency virus type 1 promoter in vitroSuppression of MHC class I gene expression by N-myc through enhancer inactivation.TNF stimulates expression of mouse MHC class I genes by inducing an NF kappa B-like enhancer binding activity which displaces constitutive factors.Tumor necrosis factor and immune interferon synergistically increase transcription of HLA class I heavy- and light-chain genes in vascular endotheliumNF-kappa B protein purification from bovine spleen: nucleotide stimulation and binding site specificityStimulation of a human T-cell clone with anti-CD3 or tumor necrosis factor induces NF-kappa B translocation but not human immunodeficiency virus 1 enhancer-dependent transcription.Activity and interleukin 1 responsiveness of SV40 enhancer motifs in a rodent immature T cell line.A family of constitutive C/EBP-like DNA binding proteins attenuate the IL-1 alpha induced, NF kappa B mediated trans-activation of the angiotensinogen gene acute-phase response element.Notch and the awesome power of genetics.Thioredoxin regulates the DNA binding activity of NF-kappa B by reduction of a disulphide bond involving cysteine 62.Adenovirus 12-mediated down-regulation of the major histocompatibility complex (MHC) class I promoter: identification of a negative regulatory element responsive to Ad12 E1ATwo purified factors bind to the same sequence in the enhancer of mouse MHC class I genes: one of them is a positive regulator induced upon differentiation of teratocarcinoma cells.Inhibition of transcription factors belonging to the rel/NF-kappa B family by a transdominant negative mutantChanges in NF-kappa B and ISGF3 DNA binding activities are responsible for differences in MHC and beta-IFN gene expression in Ad5- versus Ad12-transformed cells.kappa B elements strongly activate gene expression in non-lymphoid cells and function synergistically with NF1 elements.Developmental and tissue-specific expression of nuclear proteins that bind the regulatory element of the major histocompatibility complex class I gene.NFkappaB in neurons? The uncertainty principle in neurobiologyStable antiviral expression in BALB/c 3T3 cells carrying a beta interferon sequence behind a major histocompatibility complex promoter fragment.Negative regulation of the major histocompatibility complex class I enhancer in adenovirus type 12-transformed cells via a retinoic acid response element.Characterization of a new tissue-specific transcription factor binding to the simian virus 40 enhancer TC-II (NF-kappa B) elementAn inducible 50-kilodalton NF kappa B-like protein and a constitutive protein both bind the acute-phase response element of the angiotensinogen geneAlteration of a single nucleotide allows efficient binding of H2TF1/KBF1 to the immunoglobulin kappa enhancer B motifSpecies-specific lens activation of the thymidine kinase promoter by a single copy of the mouse alpha A-CRYBP1 site and loss of tissue specificity by multimerization.DNA-binding properties of the E1A-associated 300-kilodalton protein.Retinoic acid induction of major histocompatibility complex class I genes in NTera-2 embryonal carcinoma cells involves induction of NF-kappa B (p50-p65) and retinoic acid receptor beta-retinoid X receptor beta heterodimers.Altered binding of regulatory factors to HLA class I enhancer sequence in human tumor cell lines lacking class I antigen expression.
P2860
Q24311660-6BD6C368-05A5-4C42-97A6-6A5CD11157F5Q24318577-0D19E633-8B22-48E8-BC83-41CD952BEACEQ24320246-DC6CAD1F-A324-4E4F-A414-045A6CF50BA3Q24321796-8E0A8691-2ABB-44E6-BD58-C9CA882E6F9DQ24564833-B85942C9-9A18-4384-9C83-DCD2C6B4FAACQ24598849-815A8B80-8CD0-4AF1-B11A-64D3956ADF79Q24599406-70A947B5-077D-4AB9-96D1-80B1B5FA3C88Q24634606-725CD6F1-8D56-4609-9304-AD54A0BB7F5DQ28269339-95822336-C8E2-44BB-A69A-FFF4AF6CA95EQ28508930-108F6762-4313-4EB5-89C8-660D987EEA98Q28614547-1A27C213-6016-47FA-AE54-C79915D0ED6CQ31076639-6D668906-835C-4EEE-A024-E909D9BFBD8CQ33532900-84835545-2DA7-43C1-90FD-9F57178B416CQ33574981-E5102CF8-1BEE-42D7-9158-48EEE4077786Q33584734-FA32A296-AE3A-42AD-9E59-956E3CEB0E57Q33584911-35A66586-6D15-497E-A40B-1087F3291555Q33609443-33003ABB-3340-463B-AF72-9CE27C81C0E0Q33672681-033087A0-1B49-41AC-9137-BCF94B983AA0Q33676218-D2F8DD21-00B6-49C9-9E12-1648687DC987Q33835601-82476A5E-F8A3-4B51-9A77-85DCFF95B0D4Q33918783-1280FF2D-E3C2-4A86-804A-B9DAD17511B6Q33923274-63D07552-6EEA-48A7-BE53-B5A9440BAE67Q34287433-33676819-12FE-46E8-BDFA-0F39D53FEC19Q34313863-E314053A-A8C0-4983-A839-7FD721B75A15Q34895889-BE6A8A02-EB96-4979-A599-E5BDB94EA2F9Q35234796-286426B1-30C8-400E-AB60-67F6FF51EB67Q35926996-07E98205-CC3E-4AAD-B893-264CF6765340Q35937458-E83AFEE2-F721-4AE2-BE65-08618BA95631Q35951032-E66B97C7-7844-4DCD-83A7-672B08719464Q36356077-3240A0E1-F1CD-4CAF-BA78-F2C7F5788229Q36435841-50D81DB0-B99E-46A1-9CC5-C29B9CBA3C33Q36679871-68DCB421-F121-41F9-AC7E-4A2022A074B9Q36686575-FCB42FBF-2477-4DEB-B490-FE54BBB46116Q36705484-2239F205-0D92-4F2B-9112-319A46A75A0FQ36720562-AC32479C-4527-4911-9261-449BB9228550Q36759388-E25C9C87-AE02-4F11-9FD9-6C66FF1DE0F2Q36776019-DBF63D14-30E9-427C-BBF5-2E87676A2F22Q36817732-30F39C21-2DCD-4300-B100-C23629E92E7EQ36823476-ED417B06-1596-4E30-B39E-65AA5306B7F5Q36957042-E742FC29-1809-45B4-AC5E-48577DF1D1B6
P2860
Purification of KBF1, a common factor binding to both H-2 and beta 2-microglobulin enhancers
description
1987 nî lūn-bûn
@nan
1987 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1987 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
name
Purification of KBF1, a common ...... beta 2-microglobulin enhancers
@ast
Purification of KBF1, a common ...... beta 2-microglobulin enhancers
@en
type
label
Purification of KBF1, a common ...... beta 2-microglobulin enhancers
@ast
Purification of KBF1, a common ...... beta 2-microglobulin enhancers
@en
prefLabel
Purification of KBF1, a common ...... beta 2-microglobulin enhancers
@ast
Purification of KBF1, a common ...... beta 2-microglobulin enhancers
@en
P2093
P2860
P1433
P1476
Purification of KBF1, a common ...... beta 2-microglobulin enhancers
@en
P2093
P2860
P304
P407
P577
1987-11-01T00:00:00Z